CA
NZ
UK
AU
IND
US
…
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as well as sells liner, eyeshadow, and lip color products. It serves distributors, retailers, physicians, and directly to consumers through its e-commerce platforms, and third-party logistics and delivery providers. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Waldencast Acquisition Corp is a Nasdaq-listed special purpose acquisition company created to merge with a private operating business and provide it public-market access. Long-term growth depends on completing a value-accretive combination and the post-merger company's operating performance, which may appeal to investors seeking exposure to a selected growth platform. Public detail on the sponsor and target focus appears limited.
Principal risks are failure to complete a qualifying business combination within the SPAC's timeline, dilution from sponsor economics and redemptions, and execution and regulatory risks facing the merged company.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | -262.25M | -48.54M | -112.94M | -14.43M | -0.00M |
| Minority interest | 18.31M | 6.21M | 15.99M | - | - |
| Net income | -229.75M | -42.44M | -89.98M | -14.37M | -0.00M |
| Selling general administrative | 247.98M | 201.80M | 204.01M | 9.13M | - |
| Selling and marketing expenses | - | 43.50M | 16.30M | - | - |
| Gross profit | 123.83M | 131.73M | 141.58M | -9.13M | - |
| Reconciled depreciation | 59.18M | 60.02M | 60.50M | - | - |
| Ebit | -61.67M | -31.38M | -94.04M | -9.13M | -0.13M |
| Ebitda | -2.49M | 28.63M | -33.54M | -3.79M | - |
| Depreciation and amortization | 59.18M | 60.02M | 60.50M | 5.35M | 0.00M |
| Operating income | -61.67M | -58.58M | -81.93M | -9.13M | -0.00M |
| Other operating expenses | 333.75M | 327.42M | 300.07M | 9.13M | 0.00M |
| Interest expense | 25.09M | 17.16M | 18.91M | 5.29M | 0.00M |
| Tax provision | -14.19M | 0.11M | -6.97M | - | - |
| Interest income | - | - | - | 0.05M | - |
| Net interest income | -25.09M | -17.16M | -18.91M | 0.05M | - |
| Income tax expense | -14.19M | 0.11M | -6.97M | -0.05M | - |
| Total revenue | 272.07M | 273.87M | 218.14M | 0.00M | - |
| Total operating expenses | 185.51M | 185.28M | 223.51M | 9.13M | 0.00M |
| Cost of revenue | 148.24M | 82.12M | 76.56M | 9.13M | - |
| Total other income expense net | -200.57M | 5.01M | -31.01M | -5.29M | - |
| Net income from continuing ops | -248.06M | -48.65M | -105.97M | -14.43M | - |
| Net income applicable to common shares | - | - | - | -14.43M | -0.13M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 816.20M | 975.86M | 1090.08M | 1090.08M | 1708.60M |
| Intangible assets | 427.10M | 526.44M | 639.16M | 639.16M | - |
| Other current assets | 11.21M | 9.44M | 0.68M | 0.68M | 0.20M |
| Total liab | 316.10M | 245.92M | 290.18M | 290.18M | 56.60M |
| Total stockholder equity | 461.88M | 662.32M | 639.24M | 639.24M | 290.19M |
| Other current liab | 52.20M | 19.56M | 16.21M | 16.21M | 0.10M |
| Common stock | 0.01M | 0.01M | 0.01M | - | 345.00M |
| Capital stock | 0.01M | 0.01M | 0.01M | 0.01M | 345.00M |
| Retained earnings | -518.95M | -289.20M | -156.78M | -156.78M | -54.81M |
| Other liab | - | - | - | - | 399.73M |
| Good will | 177.57M | 329.59M | 334.62M | 334.62M | - |
| Other assets | - | - | - | - | 1361.81M |
| Cash | 31.89M | 14.80M | 8.69M | 8.69M | 1.50M |
| Total current liabilities | 74.55M | 76.89M | 72.50M | 72.50M | 0.37M |
| Current deferred revenue | - | - | 10.29M | - | - |
| Net debt | 117.12M | 167.30M | 190.55M | 170.63M | -0.00M |
| Short term debt | 2.88M | 32.24M | 22.14M | - | - |
| Short long term debt | 0.77M | 29.48M | 8.53M | 20.09M | - |
| Short long term debt total | 149.01M | 182.11M | 199.25M | - | 1.50M |
| Other stockholder equity | 981.20M | 951.26M | 796.04M | - | 0.00M |
| Total current assets | 126.94M | 103.62M | 91.04M | 91.04M | 1.71M |
| Net tangible assets | - | - | - | - | -54.81M |
| Net receivables | 29.23M | 26.28M | 19.54M | 19.26M | - |
| Long term debt | 135.75M | 137.14M | 151.26M | 159.23M | 1.50M |
| Inventory | 54.61M | 53.10M | 54.38M | 54.38M | - |
| Accounts payable | 19.46M | 25.09M | 23.87M | 23.87M | 0.27M |
| Accumulated other comprehensive income | -0.38M | 0.25M | -0.03M | - | - |
| Non currrent assets other | 0.57M | 0.54M | 0.54M | 0.54M | 345.09M |
| Non current assets total | 689.25M | 872.24M | 999.03M | 999.03M | 345.09M |
| Capital lease obligations | 12.49M | 15.49M | 17.93M | 19.92M | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 0.00M | -2.92M | -1.99M | - | -345.00M |
| Change to liabilities | - | - | - | - | 0.27M |
| Total cashflows from investing activities | 76.23M | -2.92M | -1.99M | - | -345.00M |
| Net borrowings | -25.01M | 6.11M | -21.93M | - | 1.50M |
| Total cash from financing activities | -47.22M | 5.58M | 44.33M | - | 347.32M |
| Change to operating activities | - | - | - | - | 0.13M |
| Net income | -229.75M | -48.65M | -89.98M | -116.62M | -14.43M |
| Change in cash | 15.59M | -6.27M | 12.41M | - | 1.50M |
| Begin period cash flow | 16.30M | 22.58M | 10.16M | 1.50M | 0.00M |
| End period cash flow | 31.89M | 16.30M | 22.58M | 13.44M | 1.50M |
| Total cash from operating activities | -12.82M | -8.82M | -29.77M | - | -0.82M |
| Issuance of capital stock | 0.00M | 0.00M | 70.00M | - | 338.12M |
| Depreciation | 59.18M | 60.02M | 60.50M | - | - |
| Other cashflows from investing activities | 82.50M | 0.09M | 0.05M | - | -345.00M |
| Dividends paid | - | - | 0.00M | - | - |
| Change to inventory | -0.87M | 2.58M | -1.30M | - | - |
| Change to account receivables | -2.43M | -2.85M | -2.89M | - | - |
| Other cashflows from financing activities | -0.45M | -0.53M | -3.75M | - | 9.19M |
| Change to netincome | - | - | - | - | 13.48M |
| Capital expenditures | 3.43M | 3.01M | 2.05M | 0.00M | 0.00M |
| Change in working capital | 1.97M | -6.76M | 0.10M | - | 0.13M |
| Stock based compensation | 11.80M | 9.39M | 9.23M | - | - |
| Other non cash items | 173.22M | -21.64M | -2.60M | - | 13.48M |
| Free cash flow | -16.25M | -11.83M | -31.82M | - | -0.82M |
Sector: Consumer Defensive Industry: Household & Personal Products
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PG Procter & Gamble Company |
-0.12 0.07% |
163.56 | 23.58 | 22.62 | 4.07 | 7.24 | 4.40 | 16.08 |
| LRLCF L'Oréal S.A |
4.50 0.94% |
485.50 | 41.14 | 34.25 | 6.52 | 8.59 | 6.67 | 27.76 |
| LRLCY L’Oreal Co ADR |
1.02 1.05% |
98.04 | 32.44 | 25.64 | 5.16 | 6.03 | 4.79 | 19.51 |
| UL Unilever PLC ADR |
1.18 1.81% |
66.44 | 21.53 | 16.39 | 2.66 | 7.29 | 2.77 | 12.45 |
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as well as sells liner, eyeshadow, and lip color products. It serves distributors, retailers, physicians, and directly to consumers through its e-commerce platforms, and third-party logistics and delivery providers. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Mr. Michel Brousset | Founder, Principal Accounting Officer, CEO & Director | 1973 |
| Ms. Hind Sebti | Founder, Chief Growth Officer & COO | 1979 |
| Mr. Philippe Gautier | Chief Financial Officer | 1967 |
| Mr. Felipe Dutra | Executive Chairman | 1965 |
| Mr. Michel Brousset | Founder, CEO & Director | 1973 |
| Ms. Hind Sebti | Founder & Chief Growth Officer | 1979 |
| Mr. Manuel Manfredi | Chief Financial Officer | NA |
| Elisabeth Milan | General Counsel | NA |
| Ms. Hind Sebti | Co-Founder, Chief Growth Officer & Director | 1979 |
| Mr. Manuel Manfredi | Chief Financial Officer | 1976 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.12%
Communication Services
+0.36%
Consumer Cyclical
+1.18%
Consumer Defensive
+0.81%
Energy
-2.23%
Financial Services
+0.84%
Financials
+0.52%
Healthcare
-0.61%
Industrials
+0.50%
Real Estate
+0.58%
Technology
-0.66%
Utilities
-0.06%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...